Dr. med. (I) Paolo Gozzi

Preventive cardiology

What are the goals of preventive cardiology?
To detect first signs of circulatory diseases even if they are minimal. Discovered abnormalities can be treated years sometimes even decades before they would otherwise turn into a disease.

To whom is preventive cardiology addressed?
It is addressed to all those who want to know how to best remain healthy or how to recover and how to create your personal therapy upon this knowledge.

Why should a cardiological examination be repeated at present?
In traditional examinations, only 25% of male and 10% of female patients, that need acute medical treatment later, are recognised. Using innovative methods increases the percentage of recognised problems and enables us to proceed in a targeted way.

Are there signs to assess those patients who are more at risk than others?
During a preventive cardiological examination we look for first, even minimal
signs of changes of the heart, the kidneys and the great vessels. These subtle signs allow us to assess the individual risk more in detail. Early and the most significant signs are:

Heart: hypertrophy of the left ventricle, heart valve degeneration, malformation and calcification of the aorta in the thorax (in the echocardiography);
Neck arteries, arteries of the lower limbs and abdominal artery: search for changes in the anatomy of the arterial wall, arteriosclerosis and very early signs like myointimal thickening; measuring arterial elasticity;
Arterial stiffness: an increased stiffness of vessels assessed by the CAVI method enables to evaluate cardiovascular risks and finding atherosclerosis as well as to register progress made through therapy;
Renal functioning and renal health: filtration rate, protein in the urine, anatomical kidney status and renal circulatory resistance.

Oncological cardiology

Goals of oncological cardiology
• Promoting heart and circulatory health in extreme situations of stress common in the presence of tumours;
• Recognising early signs of arteriosclerosis and diseases of the heart muscle. These can be caused by therapies and are facilitated through the illness. The aim is to prevent sequelae that occur 5-6 times more often;
• Improving therapeutic tolerance and reducing side effects.